Correlation Between Bank Rakyat and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bank Rakyat and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Rakyat and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Rakyat and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Bank Rakyat and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Rakyat with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Rakyat and Neurobo Pharmaceuticals.
Diversification Opportunities for Bank Rakyat and Neurobo Pharmaceuticals
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Bank and Neurobo is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Bank Rakyat and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Bank Rakyat is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Rakyat are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Bank Rakyat i.e., Bank Rakyat and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bank Rakyat and Neurobo Pharmaceuticals
Assuming the 90 days horizon Bank Rakyat is expected to generate 0.39 times more return on investment than Neurobo Pharmaceuticals. However, Bank Rakyat is 2.59 times less risky than Neurobo Pharmaceuticals. It trades about -0.14 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.1 per unit of risk. If you would invest 1,315 in Bank Rakyat on December 2, 2024 and sell it today you would lose (254.00) from holding Bank Rakyat or give up 19.32% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 65.57% |
Values | Daily Returns |
Bank Rakyat vs. Neurobo Pharmaceuticals
Performance |
Timeline |
Bank Rakyat |
Neurobo Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Bank Rakyat and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bank Rakyat and Neurobo Pharmaceuticals
The main advantage of trading using opposite Bank Rakyat and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Rakyat position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.Bank Rakyat vs. Bank Mandiri Persero | Bank Rakyat vs. Eurobank Ergasias Services | Bank Rakyat vs. Nedbank Group | Bank Rakyat vs. Standard Bank Group |
Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |